TR
Tony Rosenberg
CEO at Tr Advisory Services
Binningen, Basel-Country
Overview
Tony Rosenberg is a Board Member at argenx, with significant experience in the pharmaceutical industry, including roles as Chairman of the Board at Cullinan Oncology and OCULIS SA. He has a background in clinical development, drug development, and market access, with a Master of Science from the University of London and a Bachelor of Science from the University of Leicester.
Work Experience
Chairman Of The Board
2020 - Current
Board Member
2016
Chairman Of The Board
2018
Chief Executive Officer
2015
Managing Director
2015 - 2020
MPM BioImpact is a biotechnology investment firm specializing in managing early-stage venture and private/public impact.
Board Member
2015 - 2016
TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
Raised $42,500,000.00 from Deerfield, F2 Ventures, ITOCHU Corporation, ITOCHU Technology Ventures, Mitsui & Co, MPM Capital and Merck Global Health Innovation Fund.
Head M &A/Licensing
2012 - 2015
BD&L
2005 - 2012